Introduction: Platelet activation, by adenosine diphosphate (ADP) via P2Y12 receptors and thrombin via PAR1 and PAR4, is a key therapeutic target in cardiovascular disease (CVD). The efficacy of an... Click to show full abstract
Introduction: Platelet activation, by adenosine diphosphate (ADP) via P2Y12 receptors and thrombin via PAR1 and PAR4, is a key therapeutic target in cardiovascular disease (CVD). The efficacy of an...
               
Click one of the above tabs to view related content.